Literature DB >> 8362872

Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.

T R McGuire1, W A Narducci, J L Fox.   

Abstract

The stability of ondansetron hydrochloride, dexamethasone sodium phosphate, and lorazepam in 5% dextrose injection or 0.9% sodium chloride injection in polyvinyl chloride (PVC) minibags and glass bottles was studied. Triplicate solutions of 8 or 32 mg of ondansetron (as the hydrochloride salt) mixed with 20 mg of dexamethasone phosphate (as the sodium salt) with or without 2 mg of lorazepam were compounded in 50-mL PVC minibags and glass bottles containing either 5% dextrose injection or 0.9% sodium chloride injection and stored at 23-25 degrees C. Duplicate measurements were performed when drugs were added and at 1, 2, 4, 8, and 24 hours after addition. Samples of the 32-mg ondansetron admixtures were collected under aseptic conditions to inspect for precipitation and to count particles with a laser particle analyzer. Samples of all admixtures were evaluated for chemical stability by stability-indicating high-performance liquid chromatography. Ondansetron hydrochloride and dexamethasone were physically compatible and chemically stable for up to 24 hours under the study conditions. The concentration of lorazepam in PVC containers dropped below 90% of the original concentration within four hours. In addition, particle counts in lorazepam-containing solutions were higher when 0.9% sodium chloride injection was the diluent than when 5% dextrose injection was the diluent. In admixtures containing all drugs, ondansetron hydrochloride and dexamethasone sodium phosphate in 5% dextrose injection or 0.9% sodium chloride injection were stable for up to 24 hours when stored in PVC bags or glass bottles.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8362872

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  2 in total

1.  Compatibility and Physical Properties of Dexamethasone-Ondansetron Intravenous Admixture.

Authors:  Krit Suknuntha; Kotchakorn Wattanapoka; Pilor Poonpattanachai; Natanan Titipornwanich; Warunsuda Sripakdee
Journal:  Hosp Pharm       Date:  2022-03-02

2.  Stability of azasetron-dexamethasone mixture for chemotherapy-induced nausea and vomiting administration.

Authors:  Bao-Xia Fang; Fu-Chao Chen; Dan Zhu; Jun Guo; Lin-Hai Wang
Journal:  Oncotarget       Date:  2017-10-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.